MedTrace Logo

PET-FDG in Myocarditis

NCT03777839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2024-11-22

No results posted yet for this study

Summary

This study evaluates the diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) with rest perfusion imaging for the diagnosis of myocarditis. Patients with clinical suspicion of myocarditis will be recruited and undergo a rest myocardial perfusion scan and a FDG PET/CT scan following a myocardial suppression protocol.

Conditions

Interventions

DIAGNOSTIC_TEST

FDG PET/CT

FDG PET CT imaging with rest perfusion imaging

Sponsors & Collaborators

  • Montreal Heart Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03777839 on ClinicalTrials.gov